S
Shobha Swaminathan
Researcher at Rutgers University
Publications - 40
Citations - 1159
Shobha Swaminathan is an academic researcher from Rutgers University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 11, co-authored 32 publications receiving 599 citations.
Papers
More filters
Journal ArticleDOI
The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.
TL;DR: It is posited that a syndemic framework can be used to conceptualize the potential impact of COVID-19 among PLWH to inform the development of health programming services.
Journal ArticleDOI
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J. Landovitz,Deborah Donnell,Meredith E. Clement,Brett Hanscom,Leslie Cottle,Lara E. Coelho,Robinson Cabello,Suwat Chariyalertsak,Eileen F. Dunne,Ian Frank,Jorge A Gallardo-Cartagena,Aditya H Gaur,Pedro Gonzales,Ha V Tran,Juan C Hinojosa,Esper G Kallas,Colleen F Kelley,Marcelo H. Losso,J Valdez Madruga,Keren Middelkoop,Nittaya Phanuphak,Breno Santos,Omar Sued,Javier Valencia Huamaní,Edgar T. Overton,Shobha Swaminathan,Carlos del Rio,Roy M. Gulick,Paul G. Richardson,Philip Sullivan,Estelle Piwowar-Manning,Mark A. Marzinke,Craig W. Hendrix,Maoji Li,Zhe Wang,Jeanne M. Marrazzo,Eric S. Daar,Aida Asmelash,Todd T. Brown,Peter J. Anderson,Susan H. Eshleman,Marcus Bryan,Cheryl Blanchette,Jonathan Lucas,Christina Psaros,Steven A. Safren,Jeremy Sugarman,Hyman M. Scott,Joseph J. Eron,Sheldon D. Fields,Nirupama Sista,Kailazarid Gomez-Feliciano,Andrea Jennings,Ryan Kofron,Timothy H. Holtz,Katherine Shin,James F. Rooney,Kimberly Y. Smith,William Spreen,David J. Margolis,Alex R. Rinehart,Adeola Adeyeye,Myron S. Cohen,Marybeth McCauley,Beatriz Grinsztejn,Hptn (PopART) Study Team +65 more
TL;DR: In this paper, safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preve...
Journal ArticleDOI
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
Michael J. Loeffelholz,David Alland,Susan M. Butler-Wu,Utsav Pandey,Carlo Frederico Perno,Alice Nava,Karen C. Carroll,Heba H. Mostafa,Emma Davies,Ashley McEwan,Jennifer L. Rakeman,Randal C. Fowler,Jean-Michel Pawlotsky,Slim Fourati,Sukalyani Banik,Padmapriya P. Banada,Shobha Swaminathan,Soumitesh Chakravorty,Robert Kwiatkowski,VC Chu,Jo Ann Kop,Rajiv L. Gaur,Mandy L. Y. Sin,Duy Nguyen,Simranjit Singh,Na Zhang,David H. Persing +26 more
TL;DR: The Xpert test provided sensitive and accurate detection of SARS-CoV-2 in a variety of upper- and lower-respiratory-tract specimens and the high sensitivity and short time to results of approximately 45 min may impact patient management.
Journal ArticleDOI
Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.
Susan Olender,Katherine K. Perez,Alan S. Go,Bindu Balani,Eboni G. Price-Haywood,Nirav Shah,Su Wang,Theresa L. Walunas,Shobha Swaminathan,Jihad Slim,BumSik Chin,Stéphane De Wit,Shamim M Ali,Alex Soriano Viladomiu,Philip A. Robinson,Robert L. Gottlieb,Tak Yin Owen Tsang,I-Heng Lee,Richard Haubrich,Anand P Chokkalingam,Lanjia Lin,Lijie Zhong,B Nebiyou Bekele,Robertino Mera-Giler,Joel E. Gallant,Lindsey E Smith,Anu Osinusi,Diana M. Brainard,Hao Hu,Chloé Phulpin,Holly Edgar,Helena Diaz-Cuervo,Jose I Bernardino +32 more
TL;DR: In this comparative analysis, by day 14, remdesivir was associated with significantly greater recovery and 62% reduced odds of death versus standard-of-care treatment in patients with severe COVID-19.
Journal ArticleDOI
Glutathione levels and immune responses in tuberculosis patients
Vishwanath Venketaraman,Ariel Millman,Marwa Salman,Shobha Swaminathan,Mary Goetz,Alfred Lardizabal,David L. Hom,Nancy D. Connell +7 more
TL;DR: N-acetyl-cysteine treatment decreased the levels of IL-10, IL-6, TNF-alpha and IL-1, in blood cultures derived from tuberculosis patients, favoring the host immune cells to successfully control M. tuberculosis replication.